| Business Summary | | Medwave,
Inc.
is
engaged
exclusively
in
the
development,
manufacture,
and
sale
of
a
non-invasive,
continual
blood
pressure
measurement
and
monitoring
system
and
of
related
technology.
Since
its
inception,
the
Company
has
been
engaged
exclusively
in
the
development
of
devices
for
monitoring
and
measuring
blood
pressure.
Utilizing
its
proprietary
technology,
the
Company
developed
the
Vasotrac
APM205A
system,
which
monitors
blood
pressure,
providing
new
readings
approximately
every
15
heartbeats.
The
Company
has
also
developed
a
hand-held
blood
pressure
monitor,
the
Vasotrax.
This
hand-held
monitor
is
based
on
the
technology
used
in
the
Vasotrac
system. | More
from
Market Guide: Expanded
Business Description |
| Financial Summary | | Medwave,
Inc.
is
a
development
stage
company
that
is
engaged
in
the
development
of
a
non-invasive,
continual
blood
pressure
measurement
and
monitoring
system
which
provides
new
readings
every
15
heartbeats.
For
the
fiscal
year
ended
4/30/01,
revenues
increased
14%
to
$555
thousand.
Net
loss
increased
12%
to
$2.9
million.
Revenues
reflect
additional
sales
representatives
to
support
the
dealer
network.
Higher
loss
reflects
increased
sales
and
marketing
expenses. | More
from
Market Guide: Significant
Developments |
| | | | FY2001 Pay | |
| G. Kent Archibald, 60 Chairman | -- | Timothy O'Malley, 40 Pres,
CEO, Director | $180K | Mark Bakko, 41 CFO,
Sec. | -- | Dollar amounts are as of 30-Apr-2001 and compensation values are for the fiscal year ending on that date; "Pay" is salary, bonuses, etc.. |
| More
from
Market Guide on Officers & Directors: Expanded
List, Bios,
Compensation,
Options
|
|